Recombinant Protein Containing B-Cell Epitopes of Different Loxosceles Spider Toxins Generates Neutralizing Antibodies in Immunized Rabbits
Open Access
- 3 April 2018
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 9, 653
- https://doi.org/10.3389/fimmu.2018.00653
Abstract
Loxoscelism is the most important form of araneism in South America. The treatment of these accidents uses heterologous antivenoms obtained from immunization of production animals with crude loxoscelic venom. Due to the scarcity of this immunogen, new alternatives for its substitution in antivenom production are of medical interest. In the present work, three linear epitopes for loxoscelic astacin-like metalloprotease 1 (LALP1) (SLGRGCTDFGTILHE, ENNTRTIGPFDYDSIMLYGAY and KLYKCPPVNPYPGGIRPYVNV) and two for hyaluronidase (LiHYAL) (NGGIPQLGDLKAHLEKSAVDI and ILDKSATGLRIIDWEAWR) from Loxosceles intermedia spider venom were identified by SPOT-synthesis technique. One formerly characterized linear epitope (DFSGPYLPSLPTLDA) of sphingomyelinase D SMase-I from L. laeta was also chosen to constitute a new recombinant multiepitopic protein. These epitopes were combined with a previously produced chimeric multiepitopic protein (rCpLi) composed by linear and conformational B-cell epitopes from sphingomyelinase-D (SMase D) from L. intermedia venom, generating a new recombinant multiepitopic protein derived from loxoscelic toxins (rMEPLox). We demonstrated that rMEPLox is non-toxic and antibodies elicited in rabbits against this antigen present reactivity in ELISA and immunoblot assays with Brazilian L. intermedia, L. laeta, L. gaucho and L. similis spider venoms. In vivo and in vitro neutralization assays showed that anti-rMEPLox antibodies can efficiently neutralize the sphingomyelinase, hyaluronidase and metalloproteinase activity of L. intermedia venom. This study suggests that this multiepitopic protein can be a suitable candidate for experimental vaccination approaches or for antivenom production against Loxosceles spp venoms.Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (TOXINOLOGIA No. 23038000825/2011-63)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (Ed. Universal No. 472417/2013-4)
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais (PPM: 00270-16)
This publication has 45 references indexed in Scilit:
- A Novel Hyaluronidase from Brown Spider (Loxosceles intermedia) Venom (Dietrich's Hyaluronidase): From Cloning to Functional CharacterizationPLoS Neglected Tropical Diseases, 2013
- A novel expression profile of the Loxosceles intermedia spider venomous gland revealed by transcriptome analysisMolecular BioSystems, 2010
- Astacin-like metalloproteases are a gene family of toxins present in the venom of different species of the brown spider (genus Loxosceles)Biochimie, 2010
- An in vivo protective response against toxic effects of the dermonecrotic protein from Loxoscelesintermedia spider venom elicited by synthetic epitopesVaccine, 2009
- I-TASSER server for protein 3D structure predictionBMC Bioinformatics, 2008
- Identification, cloning, expression and functional characterization of an astacin-like metalloprotease toxin from Loxosceles intermedia (brown spider) venomBiochemical Journal, 2007
- Isolation and biochemical characterization of a fibrinolytic proteinase from Bothrops leucurus (white-tailed jararaca) snake venomBiochimie, 2006
- In vivo protection against Androctonus australis hector scorpion toxin and venom by immunization with a synthetic analog of toxin IIVaccine, 1997
- In vivo protection against scorpion toxins by liposomal immunizationVaccine, 1991
- Platelet aggregation and sphingomyelinase D activity of a purified toxin from the venom of loxosceles reclusaBiochimica et Biophysica Acta (BBA) - General Subjects, 1981